The standard treatment for stage III rectal cancer is chemoradiation followed by radical surgery. Recent trials have recommended a 'watch and wait' approach for patients who achieve a complete clinical response. A new study reports that 51% of patients who achieved a sustained complete clinical response did not require radical surgery.
